As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

New England Biolabs France Celebrates 10 Years!

Created “by researchers for researchers,” the scientific cooperative New England Biolabs® is recognized as the world leader in the discovery, production and supply of reagents for the life sciences industry.
To meet the enthusiastic people who accompany NEB's clients and partners in their projects ! >
NEB France celebrate 10 years @ Genopole NEB France celebrate 10 years @ Genopole

Its French affiliate arrived at Genopole in 2011 and to mark its 10th anniversary in France, the company invites you to participate in monthly activities to be held throughout 2021.

Ten years already for NEB France

Founded on the principles of ethical science, rigorous requirements to attain and maintain the best product quality possible, and a strong commitment to the environment, NEB® builds its activities on a foundation of science, people and passion.

NEB France was created in 2011 to provide its clients and partners with the highest quality services possible. It brings the innovative products developed by the parent company in the United States to the French research community.

A commitment to the environment at the heart of its activities

Logo Certified Corporation

Through sound, ecological and sustainable practices, NEB ensures the protection and preservation of natural resources, be they local or global. NEB France endeavors daily to reduce the environmental impact of its commercial processes as much as possible.

For its commitment to not only the environment but also its employees, clients and community, NEB recently earned B Corporation certificationTM.

Convinced clients, actors for change

Through its French affiliate, NEB proposes a range of innovative and renownedly efficacious products for diverse applications including NGS, nucleic acid purification, RT-qPCR and LAMP. With that offer, NEB France has won over major actors in research within Île-de-France and throughout the nation.

Genopole: a strategic and fruitful choice

NEB France launched its activities at Genopole in 2011. With its advantageous geographical location and multifold internal infrastructures, Genopole was the clear choice for capturing the Île-de-France and national markets.

With the numerous connections possible at Genopole and the proximity of the many biotechs and incubators therein, NEB France was quickly up to speed.

Stay tuned! In an upcoming podcast, NEB France Director Eric Beguec will speak on the values and commitments guiding his company and the fruitful relations his affiliate has established with other Genopole entities.  

Ten good reasons to celebrate

NEB France intends to celebrate ten years in France and at Genopole with its community. Throughout 2021, at its platform, the affiliate will propose ten participative events in the form of games or contests with such themes as education, the environment, discovery or creativity. With the events, NEB France hopes to offer its community a fun way to rediscover the company’s values and objectives.

NEB - Arts of Agar

Starting in January, the affiliate’s clients have

had the opportunity to meet the NEB team and speak about the close relations they share. In a second activity, NEB France’s clients were able to present the actions they deployed to protect and preserve the environment. Neb has also committed to making a donation to the Essonne-based Association Terre d’Avenir in their name.

With its next two events, to thank its most loyal clients, NEB France will shine a light on its laboratory talents and present a collector who possesses NEB’s oldest catalog.


To learn more about the past and future events for the anniversary celebrations, visit NEB France Celebrates 10 Years.

To learn more

NEB France Celebrates 10 Years

Games, contests and anecdotes; to visit the website and participate in the events >>click here.

Meet the team

To meet the enthusiastic people who accompany NEB’s clients and partners in their projects >>click here.

Stay in touch!

Subscribe to the NEB France newsletter to stay up to date on the latest information from NEB.

Article posted on 29 April 2021


Latest news

Alexis Biton and Paul Carouen - Genopole - visiting the Research Triangle Park (USA) accompanied by 3 Genopole's companies

Genopole strengthens its ties with the Research Triangle Park

From Monday March 20 to Thursday March 24, Genopole's Partnership & Business Development team visited the Research Triangle Park biopark in North Carolina to strengthen scientific and industrial collaborations.

l’équipe « Dystrophies musculaires progressives » du laboratoire Généthon

Shining light on a key mechanism of Duchenne muscular dystrophy

A Genethon team has provided new insights on a complex genetic mechanism involved in mitochondrial dysfunction in Duchenne muscular dystrophy.

A trio of genome sites associated with arterial hypertension

A trio of genome sites associated with arterial hypertension

Researchers from the CNRGH and PARCC have identified three loci associated with an increased risk of developing primary hyperaldosteronism, a leading cause of arterial hypertension.

Genoscope - CNS - Genopole's laboratory

The story of the domestic donkey told by its genome

Genoscope participated in the sequencing of the DNA of 250 donkeys in a study revealing the domestication of this species highly contributive to human activities to this day.

Galaxy-SynBioCAD: accelerating the arrival of green chemistry

Galaxy-SynBioCAD: accelerating the arrival of green chemistry

Conceived by the Genomics Metabolics Unit, Galaxy-SynBioCAD accelerates biological design and engineering for the production of next generation chemical compounds.

Equipe Sysfate de l'UMR 8030 - projet T-Fitness

T-FITNESS: Toward empowering CAR-T therapies for solid tumors

The Genopole team SysFate is participating in the international project T-FITNESS. The project, selected by the European Innovation Council, aims to resolve the difficulty of T-cell exhaustion in CAR-T therapies for solid tumors.

Ynsect & Genoscope : Vers la sélection génomique des insectes d’élevage

Toward the genomic selection of farmed insects

France is historically a land of livestock farming. Cows for meat or milk, sheep, pigs, fowl of all sorts; France rears them all. And insects! With its genomic selection project for Tenebrio molitor beetles, the Genopole company Ÿnsect and its biocluster partner, the sequencing center Genoscope, are making France a pioneer in insect farming.

Couverture de la revue Cell Genomics - Le plancton

A feat in the study of planktonic life

A Genoscope research team was part of a pioneering study in environmental genomics. The researchers were able to at least partially reconstitute the genomes of close to 700 eukaryote species.

Logos Istem & Généthon

A two-drug combination to treat limb-girdle muscular dystrophies and cystic fibrosis

The I-Stem and Genethon laboratories have identified a promising drug combination in the setting of three genetic diseases sharing similar molecular mechanisms.

IBISC - IA qui diagnostique et explique grâce à un réseau de neurones

An artificial intelligence to diagnose and explain

The IBISC laboratory has conceived an architecturally-innovative neural network able to provide not only a diagnostic prediction but also a biological explanation.

Christophe Lanneau - Research & Platforms Department Director

News from the human genome

The 1 April edition of Science announced the publication of the human genome with the previously-missing 8% now added to it. Comments from the Genopole Director of Research.

CNRGH - Consequences of phthalate exposure during pregnancy

Consequences of phthalate exposure during pregnancy

Jörg Tost and his team of the National Center of Human Genomics Research (CNRGH; CEA) were part of a large collaborative study aimed at determining the genome-wide correlation between phthalate exposure during pregnancy and methylation of placental DNA.

INtegrare / Généthon - Efficacité à long terme de la thérapie génique d’un déficit immunitaire

Long-term efficacy for an immunodeficiency gene therapy

A gene therapy conceived by Genethon has been shown to confer long-term efficacy against Wiskott-Aldrich syndrome, an immune deficiency disorder.

I-Stem, IPSEN & LMN recreate the human muscle-nerve system

A cellular model to recreate the human muscle-nerve system

Researchers from I-Stem, IPSEN and LMN have conceived a cellular muscle-nerve model to test the therapeutic potential of botulinum toxins in vitro.

Genoscope - CNS - Genopole's laboratory

Filling the gaps in the banana’s genome

Des chercheurs de Genoscope en collaboration avec une équipe du Cirad sont parvenus à reconstituer la séquence intégrale de chromosomes de bananier.

traitement des plaies diabétiques issu de peau et d’écailles de poissons

CERITD: Treating deep wounds with fish skin

CERITD and the South Île-de-France Medical Center are testing an innovative, natural fish-skin-based treatment for diabetic foot ulcers.


Sysfate Team: A tool to digitize organs

Sysfate at Genoscope has combined image analysis and genomics to create MULTILAYER, a tool to digitize biological tissues and organs.

muscle fiber

Signs of myopathy detected before muscle formation

An I-Stem team has revealed very early embryonic molecular signs of Duchenne muscular dystrophy occurring upstream of muscle development itself

Neurons representation - Cells affected by CMT

Gene therapy for Charcot-Marie-Tooth disease makes headway

A gene therapy for Charcot-Marie-Tooth disease has been shown to be efficacious in an animal-model study cosigned by a research team created through Genopole support.

LAST - Makeup by Global Bioenergies

Global Bioenergies launches its makeup brand

Interview with Marc Delcourt, founder and CEO of Global Bioenergies, launches its makeup brand : LAST

View all >
With the support from
Région île de France